Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Picking up steam now here in the pre.
ETRM
ETRM News out. Is short interest here really at 76%? Jesus!
Agree. Same here holding lots. For the next few weeks. Chart reversal. Looking good.
$ETRM my favorite setup for the next couple months. Company sitting on a pile of cash now with no debt. Looks to have bottomed. Turning technically as well.
You are definitely mistaken. Next earnings release is beginning of November.
If I'm not mistaking, ETRM has earnings in the morning. We need a run past 2.10. Grabbed a position at 1.90. Waiting for some anticipation.
* * $ETRM Video Chart 09-22-17 * *
Link to Video - click here to watch the technical chart video
lots off nice hit here next week will be fun imo
steez loading 1.98 thanks chart reversal in now tic toc
I got stopped out only holding AZFL
Looks like no one knows, so they are all gambling like you.
Pretty low float. Gambling at 2.12
Can someone post the share structure? I see this but don't want to figure what the B's are about if someone can do it for me.
10.2M shares
2.575M warrants at what price?
some amount of warrants in conjunction with the offering and at what price?
15,664 B stock but what is that about?
" as of August 16, 2017, the Company had outstanding 10,181,136 shares of Common Stock and 15,664 shares of Series B Preferred Stock.
In connection with the closing of the Offering, the Company entered into a warrant agency agreement (the “Warrant Agency Agreement”) with Wells Fargo Bank, National Association (“Wells Fargo”) on August 16, 2017, pursuant to which Wells Fargo will serve as the Company’s Warrant Agent for the Offering.
On August 16, 2017, the Company also issued warrants to purchase an aggregate of 2,575,000 shares of Common Stock to certain parties (each, a “Holder”) to the Securities Purchase Agreement (as amended, the “Purchase Agreement”), dated November 4, 2015, between the Company and the other parties named therein, as consideration for the waiver by each of the Holders of their right to participate in future securities offerings by the Company, which rights were granted pursuant to the Purchase Agreement. These warrants are in substantially the same form, and on the same terms as, the Warrants issued pursuant to the Offering. The Company previously disclosed in a Form 8-K filed on August 11, 2017 that the total number of warrants to be issued to the holders was 2,581,750. However, based on the final aggregate amount invested by the Holders in the Offering, the total number of warrants issued to the Holders was reduced to 2,575,000."
There's hope!! Always hope!! LoL.
And just for the record...in my entire 'I-hub career', I've only felt compelled to put one fool on block. So post away!! I'll see them!!
I guess there is always hope for me ;))
(__@ @__)
But Please..., do not take me off 'Blocked'
We're finally on the same page again.
The company owns no drug. They do utilize a particular type procedure for a semi invasive implant that deregulates the metabolic regulation of ones appetite. The stock took a big hit on Friday, and rightfully so. Stay clear ;)
I was thinking about jumping in while it's down. You kno....buy the "dip".
I think it is a good time to load. Actually, I built a large position today. SP will gradually go back to $4-5. I usually get burned when chasing a stock, and feel pretty safe investment in etrm because of no worry about the funding issue for a while.
Is it a good time to load up on this?
It is the best time to load. Still has tiny float and good drug. Will be back $4-5 range soon
And it only costs 105% to borrow the shartes
ETRM. Now in collaboration with the largest tech company in the world GOOG and on of the largest Bio in the world Glaxo. Buy
EnteroMedics is now working with GlaxoSmithKline & Verily Life Sciences ***
"EnteroMedics is now working, Galvani, is the brainchild of GlaxoSmithKline and Verily Life Sciences (an Alphabet company) that was established in 2016 to enable the research, development, and commercialization of bioelectronic medicines.
In other words, EnteroMedics is now one-third of a three company setup, which is in place to develop a technology that EnteroMedics is going to retain the exclusive rights to the US, with the other two-thirds of the team being Google, arguably the most influential technology company in the world and GlaxoSmithKline, arguably holding the same title in the pharmaceutical space and definitely as relates to health and wellness (and importantly, weight loss).
This completely changes the nature of an EnteroMedics exposure.
No longer does the company need major coverage from insurers to justify the existence of its technology. If Google and GSK can successfully apply the technology to a new product, one that these two behemoths then set out to commercialize in the US, EnteroMedics doesn’t really need to worry about driving sales on its own of the initial iteration of the product, vBloc, in order to generate revenues."
https://insiderfinancial.com/enteromedics-inc-nasdaqetrm-just-made-a-game-changing-announcement-and-markets-missed-it
And that's why they call this stock a pop and drop
* * $ETRM Video Chart 07-26-17 * *
Link to Video - click here to watch the technical chart video
I gotta ask you man......what was your purpose in showing up here?
Hey man. I bought 1500 shares a few days ago when it went up to 4.60 because of your post. So thanks.
Well I'll be damned. I might actually make some money off this stock. I hope I'm not jinxing myself
On July25, 2017, EnteroMedics Inc. (the “Company”) entered into a Collaboration Agreement with Galvani Bioelectronics Limited (“Galvani”).
Galvani is a joint venture between GlaxoSmithKline and Verily Life Sciences (an Alphabet company) that was established in 2016 to enable the research, development and commercialization of bioelectronic medicines.
Where are you getting this? Provide a link.
What is F is offline trading? You mean after hours?
ETRM + GlaxoSmithKline + Alphabet ! WOW
How can I trade offline !!!! someone please guide !!!!!
ETRM ties up with JV of GlaxoSmithKline & Verily (Alphabet (Google) Ltd company !!!!
How do I buy shares offline trading ? !!!!
Up pre-market
ST. PAUL, Minn., July 25, 2017 /PRNewswire/ -- EnteroMedics Inc. (NASDAQ: ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the Methodist Dallas Medical Center successfully completed its first implant of the Company's vBloc® Neurometabolic Therapy through the Veterans Choice Program. The surgery was performed on July 24, 2017 by Sachin Kukreja, M.D., a bariatric surgeon in Dallas, Texas.
The federal Veterans Choice Program allows veterans to have the vBloc procedure within a facility in their local community instead of at a Department of Veteran's Affairs (VA) hospital, significantly increasing the accessibility to vBloc for veterans. According to the VA, in the first quarter of FY2017, they observed a more than 30 percent increase in authorizations through the program as compared to the same period in FY2016. The company's previously announced agreement with Academy Medical covers the cost of vBloc for qualified veterans in accordance with their VA health benefits.
"There are over one million veterans battling obesity today, and it is a privilege for EnteroMedics to be able to facilitate their access to our life-changing solutions," said Dan Gladney, EnteroMedics' President, Chief Executive Officer, and Chairman of the Board. "This first VA Choice implant represents another successful step for EnteroMedics towards our goal of establishing vBloc Therapy as a standard of care for patients seeking anatomy-friendly options for weight loss."
vBloc Therapy works to control sensations of hunger using a pacemaker-like device that is implanted under the skin during a safe, minimally invasive procedure. The vBloc System gives the patient a sensation of fullness, empowering them to eat less, control their appetite, and lose weight. Studies have shown that vBloc Therapy produces meaningful weight loss while also reducing comorbidity factors related to obesity.
"It is an honor to help our veterans and their families who have served this country," said Dr. Kukreja. "With a minimally-invasive, non-anatomy-altering solution to help fight obesity, vBloc Therapy offers patients a healthier alternative to other surgical weight loss solutions."
vBloc Therapy is approved for use in people aged 18 years and older who are obese, with a BMI of 40 to 45 kg/m2, or a BMI of 35 to 39.9 kg/m2 with a related health condition such as Type 2 diabetes, high blood pressure, high cholesterol levels or obstructive sleep apnea who have had a poor response to trying to lose weight under supervision in the last 5 years.
http://www.prnewswire.com/news-releases/enteromedics-announces-first-veterans-choice-program-vbloc-implant-for-obesity-at-methodist-dallas-medical-center-300493281.html
This is where smart money starts buying buy back and hold
Too late for me. I sold yesterday. Wouldn't you know it finally goes up today.
Nihalani Rajesh has filed a new activist 13D, reporting 35.1% ownership in $ETRM - https://fintel.io/so/us/etrm and https://fintel.io/i/nihalani-rajesh
GAP & TRAPPER
TIRED OF THESE BIG BOARDS THAT CANT HOLD GAINS
SO TIRED
Followers
|
149
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
4523
|
Created
|
08/02/09
|
Type
|
Free
|
Moderators |
The Maestro® System consists of a subcutaneously implanted rechargeable neuroregulator and two electrodes that are laparoscopically implanted by a bariatric surgeon. It delivers VBLOC® vagal blocking therapy via these electrodes that are placed in contact with the trunks of the vagus nerves just above the junction between the esophagus and the stomach. The device intermittently blocks vagal nerve signals throughout the patient’s waking hours. The Maestro System is recharged using an external mobile charger and transmit coil worn by the patient. The device can be non-invasively programmed, and it can be adjusted, deactivated, reactivated or completely removed if desired.
EnteroMedics® has significant experience with vBloc® Therapy; more than 600 patients have been implanted with the Maestro System to date, some out to five years. Data on safety, efficacy and sustained weight loss with vBloc® Therapy is being collected in multiple clinical trials.
Web Page:
http://www.enteromedics.com/
http://vbloc.com
http://youtu.be/AqHBGBZQh_s
https://youtu.be/dIjHC3FAp1w
http://youtu.be/KX0MWj6ADZ0
http://youtu.be/wb9Acd0AXSE
http://youtu.be/md8fQSDWM4I
DISCLAIMER: Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have positions in the stocks or financial relationships with the company or companies discussed and may trade in the stocks mentioned. Readers are advised to conduct their own due diligence prior to considering buying or selling any stock. All information should be considered for information purposes only. No stock exchange has approved or disapproved of the information contained herein. All information is believed to be accurate and was taken from public sources, or is the opinion(s) of the author(s). (This disclaimer has been reprinted by permission of its author)
DAILY CHART:
WEEKLY CHART:
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |